{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:50:13Z","timestamp":1792057813939,"version":"4.4.0"},"reference-count":142,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s11033-021-06611-7","type":"journal-article","created":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T06:02:58Z","timestamp":1628143378000},"page":"6181-6196","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Latent tuberculosis: interaction of virulence factors in Mycobacterium tuberculosis"],"prefix":"10.1007","volume":"48","author":[{"given":"Sadhana","family":"Sundararajan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8057-5626","authenticated-orcid":false,"given":"Rajiniraja","family":"Muniyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,5]]},"reference":[{"key":"6611_CR1","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3390\/antibiotics3030317","volume":"3","author":"JC Palomino","year":"2014","unstructured":"Palomino JC, Martin A (2014) Drug resistance mechanisms in Mycobacterium tuberculosis. Antibiotics 3:317\u2013340. https:\/\/doi.org\/10.3390\/antibiotics3030317","journal-title":"Antibiotics"},{"key":"6611_CR2","unstructured":"World Health Organization (2019) WHO Global TB Report 2019"},{"key":"6611_CR3","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nature09657","volume":"469","author":"A Koul","year":"2011","unstructured":"Koul A, Arnoult E, Lounis N et al (2011) The challenge of new drug discovery for tuberculosis. Nature 469:483\u2013490. https:\/\/doi.org\/10.1038\/nature09657","journal-title":"Nature"},{"key":"6611_CR4","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s40265-018-1043-y","volume":"79","author":"AD Pranger","year":"2019","unstructured":"Pranger AD, van der Werf TS, Kosterink JGW, Alffenaar JWC (2019) The role of fluoroquinolones in the treatment of tuberculosis in 2019. Drugs 79:161\u2013171. https:\/\/doi.org\/10.1007\/s40265-018-1043-y","journal-title":"Drugs"},{"key":"6611_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2017.00084","volume":"8","author":"V Peddireddy","year":"2017","unstructured":"Peddireddy V, Doddam SN, Ahmed N (2017) Mycobacterial dormancy systems and host responses in tuberculosis. Front Immunol 8:1\u201319. https:\/\/doi.org\/10.3389\/fimmu.2017.00084","journal-title":"Front Immunol"},{"key":"6611_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2012.00411","volume":"3","author":"S Ehlers","year":"2012","unstructured":"Ehlers S, Schaible UE (2012) The granuloma in tuberculosis: dynamics of a host-pathogen collusion. Front Immunol 3:1\u201310. https:\/\/doi.org\/10.3389\/fimmu.2012.00411","journal-title":"Front Immunol"},{"key":"6611_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens7010017","author":"DM Ferraris","year":"2018","unstructured":"Ferraris DM, Miggiano R, Rossi F, Rizzi M (2018) Mycobacterium tuberculosis molecular determinants of infection, survival strategies, and vulnerable targets. Pathogens. https:\/\/doi.org\/10.3390\/pathogens7010017","journal-title":"Pathogens"},{"key":"6611_CR8","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1111\/j.1742-4658.2010.07666.x","volume":"277","author":"LS Meena","year":"2010","unstructured":"Meena LS, Rajni T (2010) Survival mechanisms of pathogenic Mycobacterium tuberculosis H37Rv. FEBS J 277:2416\u20132427. https:\/\/doi.org\/10.1111\/j.1742-4658.2010.07666.x","journal-title":"FEBS J"},{"key":"6611_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20020340","author":"W Zhai","year":"2019","unstructured":"Zhai W, Wu F, Zhang Y et al (2019) The immune escape mechanisms of Mycobacterium tuberculosis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20020340","journal-title":"Int J Mol Sci"},{"key":"6611_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002375","author":"AW Beham","year":"2011","unstructured":"Beham AW, Puellmann K, Laird R et al (2011) A TNF-regulated recombinatorial macrophage immune receptor implicated in granuloma formation in tuberculosis. PLoS Pathog. https:\/\/doi.org\/10.1371\/journal.ppat.1002375","journal-title":"PLoS Pathog"},{"key":"6611_CR11","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1111\/j.1462-5822.2009.01335.x","volume":"11","author":"S Ehrt","year":"2009","unstructured":"Ehrt S, Schnappinger D (2009) Mycobacterial survival strategies in the phagosome: Defense against host stresses. Cell Microbiol 11:1170\u20131178. https:\/\/doi.org\/10.1111\/j.1462-5822.2009.01335.x","journal-title":"Cell Microbiol"},{"key":"6611_CR12","doi-asserted-by":"publisher","first-page":"3756","DOI":"10.4049\/jimmunol.1402679","volume":"194","author":"J Li","year":"2015","unstructured":"Li J, Chai Q-Y, Zhang Y et al (2015) Mycobacterium tuberculosis Mce3E suppresses host innate immune responses by targeting ERK1\/2 signaling. J Immunol 194:3756\u20133767. https:\/\/doi.org\/10.4049\/jimmunol.1402679","journal-title":"J Immunol"},{"key":"6611_CR13","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/s41423-018-0016-0","volume":"16","author":"L Qiang","year":"2019","unstructured":"Qiang L, Wang J, Zhang Y et al (2019) Mycobacterium tuberculosis Mce2E suppresses the macrophage innate immune response and promotes epithelial cell proliferation. Cell Mol Immunol 16:380\u2013391. https:\/\/doi.org\/10.1038\/s41423-018-0016-0","journal-title":"Cell Mol Immunol"},{"key":"6611_CR14","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1099\/jmm.0.47095-0","volume":"56","author":"S El-Shazly","year":"2007","unstructured":"El-Shazly S, Ahmad S, Mustafa AS et al (2007) Internalization by HeLa cells of latex beads coated with mammalian cell entry (Mce) proteins encoded by the mce3 operon of Mycobacterium tuberculosis. J Med Microbiol 56:1145\u20131151. https:\/\/doi.org\/10.1099\/jmm.0.47095-0","journal-title":"J Med Microbiol"},{"key":"6611_CR15","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1126\/science.8367727","volume":"261","author":"S Arruda","year":"1993","unstructured":"Arruda S, Bomfim G, Knights R et al (1993) Cloning of an M. tuberculosis DNA fragment associated with entry and survival inside cells. Science (80-) 261:1454\u20131457. https:\/\/doi.org\/10.1126\/science.8367727","journal-title":"Science (80-)"},{"key":"6611_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcimb.2018.00158","volume":"8","author":"Q Chai","year":"2018","unstructured":"Chai Q, Zhang Y, Liu CH (2018) Mycobacterium tuberculosis: an adaptable pathogen associated with multiple human diseases. Front Cell Infect Microbiol 8:1\u201315. https:\/\/doi.org\/10.3389\/fcimb.2018.00158","journal-title":"Front Cell Infect Microbiol"},{"key":"6611_CR17","doi-asserted-by":"publisher","DOI":"10.5772\/30335","author":"BE Garcia-Perez","year":"2012","unstructured":"Garcia-Perez BE, Castrejon-Jimenez NS, Luna-Herrer J (2012) The role of non-phagocytic cells in mycobacterial infections. Underst Tuberc. https:\/\/doi.org\/10.5772\/30335","journal-title":"Underst Tuberc"},{"key":"6611_CR18","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1099\/mic.0.027086-0","volume":"155","author":"M de La Paz","year":"2009","unstructured":"de La Paz M, Klepp L, Nu\u00f1ez-Garc\u00eda J et al (2009) Mce3R, a TetR-type transcriptional repressor, controls the expression of a regulon involved in lipid metabolism in Mycobacterium tuberculosis. Microbiology 155:2245\u20132255. https:\/\/doi.org\/10.1099\/mic.0.027086-0","journal-title":"Microbiology"},{"key":"6611_CR19","doi-asserted-by":"publisher","unstructured":"Joon M, Bhatia S, Pasricha R et al (2010) Functional analysis of an intergenic non-coding sequence within mce1 operon of M.tuberculosis. BMC Microbiol 10:128. https:\/\/doi.org\/10.1186\/1471-2180-10-128","DOI":"10.1186\/1471-2180-10-128"},{"key":"6611_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11010-011-0733-5","volume":"352","author":"F Zhang","year":"2011","unstructured":"Zhang F, Xie JP (2011) Mammalian cell entry gene family of Mycobacterium tuberculosis. Mol Cell Biochem 352:1\u201310. https:\/\/doi.org\/10.1007\/s11010-011-0733-5","journal-title":"Mol Cell Biochem"},{"key":"6611_CR21","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1128\/JB.188.2.441-449.2006","volume":"188","author":"N Casali","year":"2006","unstructured":"Casali N, White AM, Riley LW (2006) Regulation of the Mycobacterium tuberculosis mce1 operon. J Bacteriol 188:441\u2013449. https:\/\/doi.org\/10.1128\/JB.188.2.441-449.2006","journal-title":"J Bacteriol"},{"key":"6611_CR22","doi-asserted-by":"publisher","first-page":"487","DOI":"10.4103\/0971-5916.184305","volume":"143","author":"P Singh","year":"2016","unstructured":"Singh P, Katoch VM, Mohanty KK, Chauhan DS (2016) Analysis of expression profile of mce operon genes (mce1, mce2, mce3 operon) in different Mycobacterium tuberculosis isolates at different growth phases. Indian J Med Res 143:487\u2013494. https:\/\/doi.org\/10.4103\/0971-5916.184305","journal-title":"Indian J Med Res"},{"key":"6611_CR23","doi-asserted-by":"publisher","first-page":"4376","DOI":"10.1073\/pnas.0711159105","volume":"105","author":"AK Pandey","year":"2008","unstructured":"Pandey AK, Sassetti CM (2008) Mycobacterial persistence requires the utilization of host cholesterol. Proc Natl Acad Sci USA 105:4376\u20134380. https:\/\/doi.org\/10.1073\/pnas.0711159105","journal-title":"Proc Natl Acad Sci USA"},{"key":"6611_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cmi.12800","volume":"20","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Li J, Li B et al (2018) Mycobacterium tuberculosis Mce3C promotes mycobacteria entry into macrophages through activation of \u03b22 integrin-mediated signalling pathway. Cell Microbiol 20:1\u201316. https:\/\/doi.org\/10.1111\/cmi.12800","journal-title":"Cell Microbiol"},{"key":"6611_CR25","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.micinf.2004.11.007","volume":"7","author":"A Gioffr\u00e9","year":"2005","unstructured":"Gioffr\u00e9 A, Infante E, Aguilar D et al (2005) Mutation in mce operons attenuates Mycobacterium tuberculosis virulence. Microbes Infect 7:325\u2013334. https:\/\/doi.org\/10.1016\/j.micinf.2004.11.007","journal-title":"Microbes Infect"},{"key":"6611_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0928-8244(02)00302-4","volume":"33","author":"Y Haile","year":"2002","unstructured":"Haile Y, Caugant DA, Bjune G, Wiker HG (2002) Mycobacterium tuberculosis mammalian cell entry operon (mce) homologs in Mycobacterium other than tuberculosis (MOTT). FEMS Immunol Med Microbiol 33:125\u2013132. https:\/\/doi.org\/10.1016\/S0928-8244(02)00302-4","journal-title":"FEMS Immunol Med Microbiol"},{"key":"6611_CR27","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.1128\/JB.00502-13","volume":"195","author":"MF Wipperman","year":"2013","unstructured":"Wipperman MF, Yang M, Thomas ST, Sampson NS (2013) Shrinking the fadE proteome of Mycobacterium tuberculosis: Insights into cholesterol metabolism through identification of an \u03b12\u03b22 heterotetrameric acyl coenzyme a dehydrogenase family. J Bacteriol 195:4331\u20134341. https:\/\/doi.org\/10.1128\/JB.00502-13","journal-title":"J Bacteriol"},{"key":"6611_CR28","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1128\/IAI.00893-09","volume":"78","author":"NM Nesbitt","year":"2010","unstructured":"Nesbitt NM, Yang X, Font\u00e1n P et al (2010) A thiolase of Mycobacterium tuberculosis is required for virulence and production of androstenedione and androstadienedione from cholesterol. Infect Immun 78:275\u2013282. https:\/\/doi.org\/10.1128\/IAI.00893-09","journal-title":"Infect Immun"},{"key":"6611_CR29","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/mmi.12095","volume":"87","author":"I Casabon","year":"2013","unstructured":"Casabon I, Crowe AM, Liu J, Eltis LD (2013) FadD3 is an acyl-CoA synthetase that initiates catabolism of cholesterol rings C and D in actinobacteria. Mol Microbiol 87:269\u2013283. https:\/\/doi.org\/10.1111\/mmi.12095","journal-title":"Mol Microbiol"},{"key":"6611_CR30","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3109\/10409238.2014.895700","volume":"49","author":"MF Wipperman","year":"2014","unstructured":"Wipperman MF, Sampson NS, Suzanne TT (2014) Pathogen \u2019Roid Rage: cholesterol utilization by Mycobacterium tuberculosis. Crit Rev Biochem Mol Biol 49:269\u2013293. https:\/\/doi.org\/10.3109\/10409238.2014.895700","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"6611_CR31","doi-asserted-by":"publisher","first-page":"6584","DOI":"10.1128\/JB.00488-09","volume":"191","author":"A Brzostek","year":"2009","unstructured":"Brzostek A, Pawelczyk J, Rumijowska-Galewicz A et al (2009) Mycobacterium tuberculosis is able to accumulate and utilize cholesterol. J Bacteriol 191:6584\u20136591. https:\/\/doi.org\/10.1128\/JB.00488-09","journal-title":"J Bacteriol"},{"key":"6611_CR32","doi-asserted-by":"publisher","first-page":"4319","DOI":"10.1128\/JB.00867-13","volume":"195","author":"MI Voskuil","year":"2013","unstructured":"Voskuil MI (2013) Mycobacterium tuberculosis cholesterol catabolism requires a new class of acyl coenzyme a dehydrogenase. J Bacteriol 195:4319\u20134321. https:\/\/doi.org\/10.1128\/JB.00867-13","journal-title":"J Bacteriol"},{"key":"6611_CR33","doi-asserted-by":"publisher","unstructured":"Takayama K, Wang C, Besra GS (2005) Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis genetic analysis of synthesis and processing of mycolic acid. Clin.microbiol.rev 18:81\u2013101. https:\/\/doi.org\/10.1128\/CMR.18.1.81","DOI":"10.1128\/CMR.18.1.81"},{"key":"6611_CR34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1021\/cb0500042","volume":"1","author":"Sullivan","year":"2006","unstructured":"Sullivan et al (2006) High affinity InhA inhibitors with activity against drug-resistant strains of Mycobacterium tuberculosis. ACS Chem Biol 1:43\u201353. https:\/\/doi.org\/10.1021\/cb0500042","journal-title":"ACS Chem Biol"},{"key":"6611_CR35","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1111\/j.1365-2958.2010.07446.x","volume":"78","author":"V Molle","year":"2010","unstructured":"Molle V, Gulten G, Vilch\u00e8ze C et al (2010) Phosphorylation of InhA inhibits mycolic acid biosynthesis and growth of Mycobacterium tuberculosis. Mol Microbiol 78:1591\u20131605. https:\/\/doi.org\/10.1111\/j.1365-2958.2010.07446.x","journal-title":"Mol Microbiol"},{"key":"6611_CR36","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1111\/j.1365-2958.1995.tb02276.x","volume":"15","author":"TM Wilson","year":"1995","unstructured":"Wilson TM, de Lisle GW, Collins DM (1995) Effect of inhA and katG on isoniazid resistance and virulence of Mycobacterium bovis. Mol Microbiol 15:1009\u20131015. https:\/\/doi.org\/10.1111\/j.1365-2958.1995.tb02276.x","journal-title":"Mol Microbiol"},{"key":"6611_CR37","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/MAJ.0b013e31825d32c6","volume":"345","author":"AS Kalokhe","year":"2013","unstructured":"Kalokhe AS, Shafiq M, Lee JC et al (2013) Multidrug-resistant tuberculosis drug susceptibility and molecular diagnostic testing. Am J Med Sci 345:143\u2013148. https:\/\/doi.org\/10.1097\/MAJ.0b013e31825d32c6","journal-title":"Am J Med Sci"},{"key":"6611_CR38","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1128\/JCM.01960-06","volume":"45","author":"M Caws","year":"2007","unstructured":"Caws M, Dau QT, Phan MD et al (2007) PCR-restriction fragment length polymorphism for rapid, low-cost identification of isoniazid-resistant Mycobacterium tuberculosis. J Clin Microbiol 45:1789\u20131793. https:\/\/doi.org\/10.1128\/JCM.01960-06","journal-title":"J Clin Microbiol"},{"key":"6611_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/emi.2015.42","volume":"4","author":"JN Torres","year":"2015","unstructured":"Torres JN, Paul LV, Rodwell TC et al (2015) Novel katG mutations causing isoniazid resistance in clinical M. Tuberculosis isolates. Emerg Microbes Infect 4:e42. https:\/\/doi.org\/10.1038\/emi.2015.42","journal-title":"Emerg Microbes Infect"},{"key":"6611_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-51812-7","volume":"9","author":"HNT Le","year":"2019","unstructured":"Le HNT, Hijikata M, Maeda S et al (2019) Whole genome sequencing, analyses of drug resistance-conferring mutations, and correlation with transmission of Mycobacterium tuberculosis carrying katG-S315T in Hanoi. Vietnam Sci Rep 9:1\u201314. https:\/\/doi.org\/10.1038\/s41598-019-51812-7","journal-title":"Vietnam Sci Rep"},{"key":"6611_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-018-1168-x","author":"J Isakova","year":"2018","unstructured":"Isakova J, Sovkhozova N, Vinnikov D et al (2018) Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic. BMC Microbiol. https:\/\/doi.org\/10.1186\/s12866-018-1168-x","journal-title":"BMC Microbiol"},{"key":"6611_CR42","unstructured":"World Health Organization (2016) WHO Global TB Report 2016"},{"key":"6611_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-21378-x","volume":"8","author":"P Lempens","year":"2018","unstructured":"Lempens P, Meehan CJ, Vandelannoote K et al (2018) Isoniazid resistance levels of Mycobacterium tuberculosis can largely be predicted by high-confidence resistance-conferring mutations. Sci Rep 8:1\u20139. https:\/\/doi.org\/10.1038\/s41598-018-21378-x","journal-title":"Sci Rep"},{"key":"6611_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034538","author":"D Machado","year":"2012","unstructured":"Machado D, Couto I, Perdig\u00e3o J et al (2012) Contribution of efflux to the emergence of isoniazid and multidrug resistance in Mycobacterium tuberculosis. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0034538","journal-title":"PLoS ONE"},{"key":"6611_CR45","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.tube.2017.07.014","volume":"107","author":"AN Unissa","year":"2017","unstructured":"Unissa AN, Dusthackeer VNA, Kumar MP et al (2017) Variants of katG, inhA and nat genes are not associated with mutations in efflux pump genes (mmpL3 and mmpL7) in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from India. Tuberculosis 107:144\u2013148. https:\/\/doi.org\/10.1016\/j.tube.2017.07.014","journal-title":"Tuberculosis"},{"key":"6611_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/microorganisms7030070","volume":"7","author":"G Melly","year":"2019","unstructured":"Melly G, Purdy GE (2019) Mmpl proteins in physiology and pathogenesis of M. Tuberculosis. Microorganisms 7:1\u201316. https:\/\/doi.org\/10.3390\/microorganisms7030070","journal-title":"Microorganisms"},{"key":"6611_CR47","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.ijmm.2015.03.005","volume":"305","author":"P Sandhu","year":"2015","unstructured":"Sandhu P, Akhter Y (2015) The internal gene duplication and interrupted coding sequences in the MmpL genes of Mycobacterium tuberculosis: towards understanding the multidrug transport in an evolutionary perspective. Int J Med Microbiol 305:413\u2013423. https:\/\/doi.org\/10.1016\/j.ijmm.2015.03.005","journal-title":"Int J Med Microbiol"},{"key":"6611_CR48","first-page":"110","volume":"56","author":"MK Munir","year":"2017","unstructured":"Munir MK, Saqib M, Rehman S et al (2017) Type and frequency of mutations in katG and rpoB genes in multi-drug resistant strains of Mycobacterium Tuberculosis complex. Pak J Med Res 56:110\u2013115","journal-title":"Pak J Med Res"},{"key":"6611_CR49","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/biof.5520100219","volume":"10","author":"DR Sherman","year":"1999","unstructured":"Sherman DR, Mdluli K, Hickey MJ et al (1999) AhpC, oxidative stress and drug resistance in Mycobacterium tuberculosis. BioFactors 10:211\u2013217. https:\/\/doi.org\/10.1002\/biof.5520100219","journal-title":"BioFactors"},{"key":"6611_CR50","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1054\/tuld.1998.0002","volume":"79","author":"S Ramaswamy","year":"1998","unstructured":"Ramaswamy S, Musser JM (1998) Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis 79:3\u201329. https:\/\/doi.org\/10.1054\/tuld.1998.0002","journal-title":"Tuber Lung Dis"},{"key":"6611_CR51","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1128\/JB.188.7.2674-2680.2006","volume":"188","author":"E Pag\u00e1n-Ramos","year":"2006","unstructured":"Pag\u00e1n-Ramos E, Master SS, Pritchett CL et al (2006) Molecular and physiological effects of mycobacterial oxyR inactivation. J Bacteriol 188:2674\u20132680. https:\/\/doi.org\/10.1128\/JB.188.7.2674-2680.2006","journal-title":"J Bacteriol"},{"key":"6611_CR52","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.tube.2018.08.001","volume":"112","author":"JJ Franceschelli","year":"2018","unstructured":"Franceschelli JJ, Belardinelli JM, Tong P et al (2018) A katG S315T or an ahpC promoter mutation mediate Mycobacterium tuberculosis resistance to 2-thiophen carboxylic acid hydrazide, an inhibitor resembling the anti-tubercular drugs Isoniazid and Ethionamide. Tuberculosis 112:69\u201378","journal-title":"Tuberculosis"},{"key":"6611_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0119628","volume":"10","author":"M Seifert","year":"2015","unstructured":"Seifert M, Catanzaro D, Catanzaro A, Rodwell TC (2015) Genetic mutations associated with isoniazid resistance in Mycobacterium tuberculosis: a systematic review. PLoS ONE 10:1\u201313. https:\/\/doi.org\/10.1371\/journal.pone.0119628","journal-title":"PLoS ONE"},{"key":"6611_CR54","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1128\/AAC.00112-06","volume":"50","author":"MH Hazb\u00f3n","year":"2006","unstructured":"Hazb\u00f3n MH, Brimacombe M, Del Valle MB et al (2006) Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 50:2640\u20132649. https:\/\/doi.org\/10.1128\/AAC.00112-06","journal-title":"Antimicrob Agents Chemother"},{"key":"6611_CR55","doi-asserted-by":"publisher","first-page":"3994","DOI":"10.1128\/AAC.00222-16","volume":"60","author":"SB Georghiou","year":"2016","unstructured":"Georghiou SB, Seifert M, Catanzaro D et al (2016) Frequency and distribution of tuberculosis resistance-associated mutations between Mumbai, Moldova, and Eastern Cape. Antimicrob Agents Chemother 60:3994\u20134004. https:\/\/doi.org\/10.1128\/AAC.00222-16","journal-title":"Antimicrob Agents Chemother"},{"key":"6611_CR56","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/1120009X.2020.1716479","volume":"32","author":"AA Haratiasl","year":"2020","unstructured":"Haratiasl AA, Hamzelou G, Amini S et al (2020) Molecular identification of mutations conferring resistance to rifampin, isoniazid and pyrazinamide among Mycobacterium tuberculosis isolates from Iran. J Chemother 32:75\u201382. https:\/\/doi.org\/10.1080\/1120009X.2020.1716479","journal-title":"J Chemother"},{"key":"6611_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41426-018-0184-0","author":"L Liu","year":"2018","unstructured":"Liu L, Jiang F, Chen L et al (2018) The impact of combined gene mutations in inhA and ahpC genes on high levels of isoniazid resistance amongst katG non-315 in multidrug-resistant tuberculosis isolates from China. Emerg Microbes Infect. https:\/\/doi.org\/10.1038\/s41426-018-0184-0","journal-title":"Emerg Microbes Infect"},{"key":"6611_CR58","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jgar.2019.08.005","volume":"20","author":"G Li","year":"2020","unstructured":"Li G, Zhang J, Jiang Y et al (2020) Cross-resistance of isoniazid, para-aminosalicylic acid and pasiniazid against isoniazid-resistant Mycobacterium tuberculosis isolates in China. J Glob Antimicrob Resist 20:275\u2013281. https:\/\/doi.org\/10.1016\/j.jgar.2019.08.005","journal-title":"J Glob Antimicrob Resist"},{"key":"6611_CR59","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1371\/journal.pone.0081985","volume":"8","author":"E Purwantini","year":"2013","unstructured":"Purwantini E, Mukhopadhyay B (2013) Rv0132c of Mycobacterium tuberculosis encodes a coenzyme F 420-dependent hydroxymycolic acid dehydrogenase. PLoS ONE 8:4\u201312. https:\/\/doi.org\/10.1371\/journal.pone.0081985","journal-title":"PLoS ONE"},{"key":"6611_CR60","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.chembiol.2013.11.011","volume":"21","author":"H Marrakchi","year":"2014","unstructured":"Marrakchi H, Lan\u00e9elle MA, Daff\u00e9 M (2014) Mycolic acids: structures, biosynthesis, and beyond. Chem Biol 21:67\u201385. https:\/\/doi.org\/10.1016\/j.chembiol.2013.11.011","journal-title":"Chem Biol"},{"key":"6611_CR61","doi-asserted-by":"publisher","unstructured":"Glickman MS, Cahill SM, Jacobs WR (2001) The Mycobacterium tuberculosis cmaA2 gene encodes a mycolic acid trans- cyclopropane synthetase. J Biol Chem 276:2228\u20132233. https:\/\/doi.org\/10.1074\/jbc.C000652200","DOI":"10.1074\/jbc.C000652200"},{"key":"6611_CR62","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1046\/j.1365-2958.2000.01882.x","volume":"36","author":"E Dubnau","year":"2000","unstructured":"Dubnau E, Chan J, Raynaud C et al (2000) Oxygenated mycolic acids are necessary for virulence of Mycobacterium tuberculosis in mice. Mol Microbiol 36:630\u2013637. https:\/\/doi.org\/10.1046\/j.1365-2958.2000.01882.x","journal-title":"Mol Microbiol"},{"key":"6611_CR63","doi-asserted-by":"publisher","DOI":"10.1172\/JCI27335.1660","author":"V Rao","year":"2006","unstructured":"Rao V, Gao F, Chen B, Glickman MS (2006) Trans-cyclopropanation of mycolic acids on trehalose dimycolate suppresses. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI27335.1660","journal-title":"J Clin Invest"},{"key":"6611_CR64","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1084\/jem.20041668","volume":"201","author":"V Rao","year":"2005","unstructured":"Rao V, Fujiwara N, Porcelli SA, Glickman MS (2005) Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule. J Exp Med 201:535\u2013543. https:\/\/doi.org\/10.1084\/jem.20041668","journal-title":"J Exp Med"},{"key":"6611_CR65","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1128\/mmbr.00010-14","volume":"78","author":"NK Dutta","year":"2014","unstructured":"Dutta NK, Karakousis PC (2014) Latent tuberculosis infection: myths, models, and molecular mechanisms. Microbiol Mol Biol Rev 78:343\u2013371. https:\/\/doi.org\/10.1128\/mmbr.00010-14","journal-title":"Microbiol Mol Biol Rev"},{"key":"6611_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/mBio.00222-13","volume":"4","author":"D Sambandan","year":"2013","unstructured":"Sambandan D, Dao DN, Weinrick BC et al (2013) Keto-Mycolic acid-dependent pellicle formation confers tolerance to drug-sensitive Mycobacterium tuberculosis. MBio 4:1\u201310. https:\/\/doi.org\/10.1128\/mBio.00222-13","journal-title":"MBio"},{"key":"6611_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/metabo11020088","volume":"11","author":"DP Shan Chang","year":"2021","unstructured":"Shan Chang DP, Guan XL (2021) Metabolic versatility of Mycobacterium tuberculosis during infection and dormancy. Metabolites 11:1\u201321. https:\/\/doi.org\/10.3390\/metabo11020088","journal-title":"Metabolites"},{"key":"6611_CR68","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s00253-008-1397-2","volume":"78","author":"K C\u00f4tes","year":"2008","unstructured":"C\u00f4tes K, Bakala N\u2019Goma JC, Dhouib R et al (2008) Lipolytic enzymes in Mycobacterium tuberculosis. Appl Microbiol Biotechnol 78:741\u2013749. https:\/\/doi.org\/10.1007\/s00253-008-1397-2","journal-title":"Appl Microbiol Biotechnol"},{"key":"6611_CR69","doi-asserted-by":"publisher","first-page":"9342","DOI":"10.1073\/pnas.91.20.9342","volume":"91","author":"G Harth","year":"1994","unstructured":"Harth G, Clemens DL, Horwitz MA (1994) Glutamine synthetase of Mycobacterium tuberculosis: extracellular release and characterization of its enzymatic activity. Proc Natl Acad Sci U S A 91:9342\u20139346. https:\/\/doi.org\/10.1073\/pnas.91.20.9342","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6611_CR70","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1046\/j.1365-2958.2002.03009.x","volume":"45","author":"C Raynaud","year":"2002","unstructured":"Raynaud C, Guilhot C, Rauzier J et al (2002) Phospholipases C are involved in the virulence of Mycobacterium tuberculosis. Mol Microbiol 45:203\u2013217. https:\/\/doi.org\/10.1046\/j.1365-2958.2002.03009.x","journal-title":"Mol Microbiol"},{"key":"6611_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2180-14-128","volume":"14","author":"PA Assis","year":"2014","unstructured":"Assis PA, Esp\u00edndola MS, Paula-Silva FW et al (2014) Mycobacterium tuberculosis expressing phospholipase C subverts PGE 2 synthesis and induces necrosis in alveolar macrophages. BMC Microbiol 14:1\u201310. https:\/\/doi.org\/10.1186\/1471-2180-14-128","journal-title":"BMC Microbiol"},{"key":"6611_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep16918","volume":"5","author":"F Le Chevalier","year":"2015","unstructured":"Le Chevalier F, Cascioferro A, Frigui W et al (2015) Revisiting the role of phospholipases C in virulence and the lifecycle of Mycobacterium tuberculosis. Sci Rep 5:1\u201313. https:\/\/doi.org\/10.1038\/srep16918","journal-title":"Sci Rep"},{"key":"6611_CR73","doi-asserted-by":"publisher","unstructured":"Fisher AB, Jain M (2009) Phospholipases: degradation of phospholipids in membranes and emulsions. Encycl Life Sci. https:\/\/doi.org\/10.1002\/9780470015902.a0001394","DOI":"10.1002\/9780470015902.a0001394"},{"key":"6611_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2017.00050","volume":"8","author":"T Villase\u00f1or","year":"2017","unstructured":"Villase\u00f1or T, Madrid-Paulino E, Maldonado-Bravo R et al (2017) Activation of the Wnt pathway by Mycobacterium tuberculosis: a Wnt-Wnt situation. Front Immunol 8:1\u201316. https:\/\/doi.org\/10.3389\/fimmu.2017.00050","journal-title":"Front Immunol"},{"key":"6611_CR75","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.bbalip.2010.08.007","volume":"1801","author":"JC Bakala N\u2019Goma","year":"2010","unstructured":"Bakala N\u2019Goma JC, Schu\u00e9 M, Carri\u00e8re F et al (2010) Evidence for the cytotoxic effects of Mycobacterium tuberculosis phospholipase C towards macrophages. Biochim Biophys Acta - Mol Cell Biol Lipids 1801:1305\u20131313. https:\/\/doi.org\/10.1016\/j.bbalip.2010.08.007","journal-title":"Biochim Biophys Acta - Mol Cell Biol Lipids"},{"key":"6611_CR76","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.ijbiomac.2020.03.037","volume":"153","author":"B Kumari","year":"2020","unstructured":"Kumari B (2020) Rv2037c, a stress induced conserved hypothetical protein of Mycobacterium tuberculosis, is a phospholipase: Role in cell wall modulation and intracellular survival. Biol Macromol 153:817\u2013835. https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.03.037","journal-title":"Biol Macromol"},{"key":"6611_CR77","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1128\/iai.64.8.3259-3266.1996","volume":"64","author":"KA Johansen","year":"1996","unstructured":"Johansen KA, Gill RE, Vasil ML (1996) Biochemical and molecular analysis of phospholipase C and phospholipase D activity in Mycobacteria. Infect Immun 64:3259\u20133266. https:\/\/doi.org\/10.1128\/iai.64.8.3259-3266.1996","journal-title":"Infect Immun"},{"key":"6611_CR78","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1128\/JCM.43.2.533-538.2005","volume":"43","author":"S Talarico","year":"2005","unstructured":"Talarico S, Durmaz R, Yang Z (2005) Insertion- and deletion-associated genetic diversity of Mycobacterium tuberculosis phospholipase C-encoding genes among 106 clinical isolates from Turkey. J Clin Microbiol 43:533\u2013538. https:\/\/doi.org\/10.1128\/JCM.43.2.533-538.2005","journal-title":"J Clin Microbiol"},{"key":"6611_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00920","author":"HJ Lee","year":"2018","unstructured":"Lee HJ, Ko HJ, Song DK, Jung YJ (2018) Lysophosphatidylcholine promotes phagosome maturation and regulates inflammatory mediator production through the protein kinase a-phosphatidylinositol 3 kinase-p38 mitogen-activated protein kinase signaling pathway during Mycobacterium tuberculosis infect. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2018.00920","journal-title":"Front Immunol"},{"key":"6611_CR80","doi-asserted-by":"publisher","first-page":"5062","DOI":"10.1002\/jcb.27783","volume":"120","author":"R Paroha","year":"2019","unstructured":"Paroha R, Chaurasiya SK, Chourasia R (2019) Phospholipase C-\u03b32 promotes intracellular survival of Mycobacteria. J Cell Biochem 120:5062\u20135071. https:\/\/doi.org\/10.1002\/jcb.27783","journal-title":"J Cell Biochem"},{"key":"6611_CR81","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/35021074","volume":"406","author":"JD McKinney","year":"2000","unstructured":"McKinney JD, Bentrup HZ, K, Mu\u00f1oz-Elias EJ, et al (2000) Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature 406:735\u2013738. https:\/\/doi.org\/10.1038\/35021074","journal-title":"Nature"},{"key":"6611_CR82","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1099\/mic.0.033084-0","volume":"156","author":"M Gengenbacher","year":"2010","unstructured":"Gengenbacher M, Rao SPS, Pethe K, Dick T (2010) Nutrient-starved, non-replicating Mycobacterium tuberculosis requires respiration, ATP synthase and isocitrate lyase for maintenance of ATP homeostasis and viability. Microbiology 156:81\u201387. https:\/\/doi.org\/10.1099\/mic.0.033084-0","journal-title":"Microbiology"},{"key":"6611_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12918-017-0496-z","volume":"11","author":"VA L\u00f3pez-Agudelo","year":"2017","unstructured":"L\u00f3pez-Agudelo VA, Baena A, Ramirez-Malule H et al (2017) Metabolic adaptation of two in silico mutants of Mycobacterium tuberculosis during infection. BMC Syst Biol 11:1\u201318. https:\/\/doi.org\/10.1186\/s12918-017-0496-z","journal-title":"BMC Syst Biol"},{"key":"6611_CR84","doi-asserted-by":"publisher","first-page":"E2225","DOI":"10.1073\/pnas.1617655114","volume":"114","author":"S Puckett","year":"2017","unstructured":"Puckett S, Trujillo C, Wang Z et al (2017) Glyoxylate detoxification is an essential function of malate synthase required for carbon assimilation in Mycobacterium tuberculosis. Proc Natl Acad Sci USA 114:E2225\u2013E2232. https:\/\/doi.org\/10.1073\/pnas.1617655114","journal-title":"Proc Natl Acad Sci USA"},{"key":"6611_CR85","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.drudis.2017.04.012","volume":"22","author":"RP Bhusal","year":"2017","unstructured":"Bhusal RP, Bashiri G, Kwai BXC et al (2017) Targeting isocitrate lyase for the treatment of latent tuberculosis. Drug Discov Today 22:1008\u20131016. https:\/\/doi.org\/10.1016\/j.drudis.2017.04.012","journal-title":"Drug Discov Today"},{"key":"6611_CR86","doi-asserted-by":"publisher","first-page":"9819","DOI":"10.1073\/pnas.1000715107","volume":"107","author":"J Marrero","year":"2010","unstructured":"Marrero J, Rhee KY, Schnappinger D et al (2010) Gluconeogenic carbon flow of tricarboxylic acid cycle intermediates is critical for Mycobacterium tuberculosis to establish and maintain infection. Proc Natl Acad Sci USA 107:9819\u20139824. https:\/\/doi.org\/10.1073\/pnas.1000715107","journal-title":"Proc Natl Acad Sci USA"},{"key":"6611_CR87","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/jid.2014.371","volume":"135","author":"H Sierra","year":"2015","unstructured":"Sierra H, Cordova M, Chen CSJ, Rajadhyaksha M (2015) Confocal imaging-guided laser ablation of basal cell carcinomas: an ex vivo study. J Invest Dermatol 135:612\u2013615. https:\/\/doi.org\/10.1038\/jid.2014.371","journal-title":"J Invest Dermatol"},{"key":"6611_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5306","author":"M Nandakumar","year":"2014","unstructured":"Nandakumar M, Nathan C, Rhee KY (2014) Isocitrate lyase mediates broad antibiotic tolerance in Mycobacterium tuberculosis. Nat Commun. https:\/\/doi.org\/10.1038\/ncomms5306","journal-title":"Nat Commun"},{"key":"6611_CR89","doi-asserted-by":"publisher","first-page":"6554","DOI":"10.1073\/pnas.1219375110","volume":"110","author":"H Eoh","year":"2013","unstructured":"Eoh H, Rhee KY (2013) Multifunctional essentiality of succinate metabolism in adaptation to hypoxia in Mycobacterium tuberculosis. Proc Natl Acad Sci USA 110:6554\u20136559. https:\/\/doi.org\/10.1073\/pnas.1219375110","journal-title":"Proc Natl Acad Sci USA"},{"key":"6611_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0138436","volume":"10","author":"HJ Gutka","year":"2015","unstructured":"Gutka HJ, Wang Y, Franzblau SG, Movahedzadeh F (2015) Glpx gene in mycobacterium tuberculosis is required for in vitro gluconeogenic growth and in-vivo survival. PLoS ONE 10:1\u201315. https:\/\/doi.org\/10.1371\/journal.pone.0138436","journal-title":"PLoS ONE"},{"key":"6611_CR91","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.chom.2007.09.006","volume":"2","author":"KH Rohde","year":"2007","unstructured":"Rohde KH, Abramovitch RB, Russell DG (2007) Mycobacterium tuberculosis invasion of macrophages: linking bacterial gene expression to environmental cues. Cell Host Microbe 2:352\u2013364. https:\/\/doi.org\/10.1016\/j.chom.2007.09.006","journal-title":"Cell Host Microbe"},{"key":"6611_CR92","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.bbrc.2015.01.079","volume":"458","author":"D Tripathi","year":"2015","unstructured":"Tripathi D, Kant S, Garg R, Bhatnagar R (2015) Low expression level of glnA1 accounts for absence of cell wall associated poly-L-glutamate\/glutamine in Mycobacterium smegmatis. Biochem Biophys Res Commun 458:240\u2013245. https:\/\/doi.org\/10.1016\/j.bbrc.2015.01.079","journal-title":"Biochem Biophys Res Commun"},{"key":"6611_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/35085034","volume":"2","author":"DG Russell","year":"2001","unstructured":"Russell DG (2001) Mycobacterium tuberculosis: here today, and here tomorrow. Nat Rev Mol Cell Biol 2:1\u20139. https:\/\/doi.org\/10.1038\/35085034","journal-title":"Nat Rev Mol Cell Biol"},{"key":"6611_CR94","doi-asserted-by":"publisher","first-page":"22477","DOI":"10.1074\/jbc.M401652200","volume":"279","author":"R Mehta","year":"2004","unstructured":"Mehta R, Pearson JT, Mahajan S et al (2004) Adenylylation and catalytic properties of Mycobacterium tuberculosis glutamine synthetase expressed in Escherichia coli versus Mycobacteria. J Biol Chem 279:22477\u201322482. https:\/\/doi.org\/10.1074\/jbc.M401652200","journal-title":"J Biol Chem"},{"key":"6611_CR95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/373516","volume":"2013","author":"P Ponnan","year":"2013","unstructured":"Ponnan P, Gupta S, Chopra M et al (2013) 2D-QSAR, docking studies, and in silico ADMET prediction of polyphenolic acetates as substrates for protein acetyltransferase function of glutamine synthetase of Mycobacterium tuberculosis. ISRN Struct Biol 2013:1\u201312. https:\/\/doi.org\/10.1155\/2013\/373516","journal-title":"ISRN Struct Biol"},{"key":"6611_CR96","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1111\/j.1365-2958.2005.04899.x","volume":"58","author":"G Harth","year":"2005","unstructured":"Harth G, Masle\u0161a-Gali\u0107 S, Tullius MV, Horwitz MA (2005) All four Mycobacterium tuberculosis glnA genes encode glutamine synthetase activities but only GlnA1 is abundantly expressed and essential for bacterial homeostasis. Mol Microbiol 58:1157\u20131172. https:\/\/doi.org\/10.1111\/j.1365-2958.2005.04899.x","journal-title":"Mol Microbiol"},{"key":"6611_CR97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2018.02143","volume":"9","author":"N Rakovitsky","year":"2018","unstructured":"Rakovitsky N, Oz MB, Goldberg K et al (2018) The unexpected essentiality of glnA2 in Mycobacterium smegmatis is salvaged by overexpression of the global nitrogen regulator glnR, but not by L-, D-or iso-glutamine. Front Microbiol 9:1\u20138. https:\/\/doi.org\/10.3389\/fmicb.2018.02143","journal-title":"Front Microbiol"},{"key":"6611_CR98","doi-asserted-by":"publisher","first-page":"3927","DOI":"10.1128\/IAI.71.7.3927-3936.2003","volume":"71","author":"MV Tullius","year":"2003","unstructured":"Tullius MV, Harth G, Horwitz MA (2003) Glutamine synthetase GlnA1 is essential for growth of Mycobacterium tuberculosis in human THP-1 macrophages and guinea pigs. Infect Immun 71:3927\u20133936. https:\/\/doi.org\/10.1128\/IAI.71.7.3927-3936.2003","journal-title":"Infect Immun"},{"key":"6611_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2180-1-26","volume":"1","author":"BH Miller","year":"2001","unstructured":"Miller BH, Shinnick TM (2001) Identification of two Mycobacterium tuberculosis H37Rv ORFs involved in resistance to killing by human macrophages. BMC Microbiol 1:1\u201313. https:\/\/doi.org\/10.1186\/1471-2180-1-26","journal-title":"BMC Microbiol"},{"key":"6611_CR100","doi-asserted-by":"publisher","unstructured":"Theron A, Roth RL, Hoppe H, et al (2017) Differential inhibition of adenylylated and deadenylylated forms of M. tuberculosis glutamine synthetase as a drug discovery platform. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0185068","DOI":"10.1371\/journal.pone.0185068"},{"key":"6611_CR101","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1099\/mic.0.28942-0","volume":"152","author":"CA Pashley","year":"2006","unstructured":"Pashley CA, Brown AC, Robertson D, Parish T (2006) Identification of the Mycobacterium tuberculosis GlnE promoter and its response to nitrogen availability. Microbiology 152:2727\u20132734. https:\/\/doi.org\/10.1099\/mic.0.28942-0","journal-title":"Microbiology"},{"key":"6611_CR102","doi-asserted-by":"publisher","first-page":"5040","DOI":"10.1128\/AEM.02880-10","volume":"77","author":"P Carroll","year":"2011","unstructured":"Carroll P, Faray-Kele MC, Parish T (2011) Identifying vulnerable pathways in Mycobacterium tuberculosis by using a knockdown approach. Appl Environ Microbiol 77:5040\u20135043. https:\/\/doi.org\/10.1128\/AEM.02880-10","journal-title":"Appl Environ Microbiol"},{"key":"6611_CR103","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.tube.2006.12.003","volume":"87","author":"R Read","year":"2007","unstructured":"Read R, Pashley CA, Smith D, Parish T (2007) The role of GlnD in ammonia assimilation in Mycobacterium tuberculosis. Tuberculosis 87:384\u2013390","journal-title":"Tuberculosis"},{"key":"6611_CR104","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.jmb.2004.07.083","volume":"342","author":"G Wisedchaisri","year":"2004","unstructured":"Wisedchaisri G, Holmes RK, Hol WGJ (2004) Crystal structure of an IdeR-DNA complex reveals a conformational change in activated IdeR for base-specific interactions. J Mol Biol 342:1155\u20131169. https:\/\/doi.org\/10.1016\/j.jmb.2004.07.083","journal-title":"J Mol Biol"},{"key":"6611_CR105","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1128\/JB.188.2.424-430.2006","volume":"188","author":"GM Rodriguez","year":"2006","unstructured":"Rodriguez GM, Smith I (2006) Identification of an ABC transporter required for iron acquisition and virulence in Mycobacterium tuberculosis. J Bacteriol 188:424\u2013430. https:\/\/doi.org\/10.1128\/JB.188.2.424-430.2006","journal-title":"J Bacteriol"},{"key":"6611_CR106","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/infdis\/119.1.11","volume":"119","author":"I Kochan","year":"1969","unstructured":"Kochan I (1969) Mechanism of tuberculostasis in mammalian serum. I. Role of transferrin in human serum tuberculostasis. J Infect Dis 119:11\u201318. https:\/\/doi.org\/10.1093\/infdis\/119.1.11","journal-title":"J Infect Dis"},{"key":"6611_CR107","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1073\/pnas.97.3.1252","volume":"97","author":"JJ De Voss","year":"2000","unstructured":"De Voss JJ, Rutter K, Schroeder BG et al (2000) The salicylate-derived mycobactin siderophores of Mycobacterium tuberculosis are essential for growth in macrophages. Proc Natl Acad Sci USA 97:1252\u20131257. https:\/\/doi.org\/10.1073\/pnas.97.3.1252","journal-title":"Proc Natl Acad Sci USA"},{"key":"6611_CR108","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1128\/JB.00359-16","volume":"198","author":"M Sritharan","year":"2016","unstructured":"Sritharan M (2016) Iron Homeostasis in Mycobacterium tuberculosis: mechanistic insights into siderophore-mediated iron uptake. J Bacteriol 198:2399\u20132409. https:\/\/doi.org\/10.1128\/JB.00359-16","journal-title":"J Bacteriol"},{"key":"6611_CR109","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1128\/CVI.00125-06","volume":"13","author":"VC Yeruva","year":"2006","unstructured":"Yeruva VC, Duggirala S, Lakshmi V et al (2006) Identification and characterization of a major cell wall-associated iron-regulated envelope protein (Irep-28) in Mycobacterium tuberculosis. Clin Vaccine Immunol 13:1137\u20131142. https:\/\/doi.org\/10.1128\/CVI.00125-06","journal-title":"Clin Vaccine Immunol"},{"key":"6611_CR110","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/10408410600709768","volume":"32","author":"S Ranjan","year":"2006","unstructured":"Ranjan S, Yellaboina S, Ranjan A (2006) IdeR in mycobacteria: from target recognition to physiological function. Crit Rev Microbiol 32:69\u201375. https:\/\/doi.org\/10.1080\/10408410600709768","journal-title":"Crit Rev Microbiol"},{"key":"6611_CR111","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1128\/JB.186.2.374-382.2004","volume":"186","author":"BBD LaMarca","year":"2004","unstructured":"LaMarca BBD, Zhu W, Arceneaux JEL et al (2004) Participation of fad and mbt Genes in synthesis of mycobactin in Mycobacterium smegmatis. J Bacteriol 186:374\u2013382. https:\/\/doi.org\/10.1128\/JB.186.2.374-382.2004","journal-title":"J Bacteriol"},{"key":"6611_CR112","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1128\/iai.63.11.4284-4289.1995","volume":"64","author":"MP Schmitt","year":"1996","unstructured":"Schmitt MP, Predich M, Doukhan L et al (1996) Erratum: Characterization of an iron-dependent regulatory protein (IdeR) of Mycobacterium tuberculosis as a functional homolog of the diphtheria toxin repressor (DtxR) from Corynebacterium diphtheriae (Infection and Immunity 63:11 (4289)). Infect Immun 64:681. https:\/\/doi.org\/10.1128\/iai.63.11.4284-4289.1995","journal-title":"Infect Immun"},{"key":"6611_CR113","doi-asserted-by":"publisher","first-page":"53554","DOI":"10.1074\/jbc.M407385200","volume":"279","author":"CJ Chou","year":"2004","unstructured":"Chou CJ, Wisedchaisri G, Monfeli RR et al (2004) Functional studies of the Mycobacterium tuberculosis iron-dependent regulator. J Biol Chem 279:53554\u201353561. https:\/\/doi.org\/10.1074\/jbc.M407385200","journal-title":"J Biol Chem"},{"key":"6611_CR114","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.tim.2006.05.006","volume":"14","author":"GM Rodriguez","year":"2006","unstructured":"Rodriguez GM (2006) Control of iron metabolism in Mycobacterium tuberculosis. Trends Microbiol 14:320\u2013327. https:\/\/doi.org\/10.1016\/j.tim.2006.05.006","journal-title":"Trends Microbiol"},{"key":"6611_CR115","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/mmi.12441","volume":"91","author":"R Pandey","year":"2014","unstructured":"Pandey R, Rodriguez GM (2014) IdeR is required for iron homeostasis and virulence in Mycobacterium tuberculosis. Mol Microbiol 91:98\u2013109. https:\/\/doi.org\/10.1111\/mmi.12441","journal-title":"Mol Microbiol"},{"key":"6611_CR116","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-04748-9","volume":"7","author":"A Rohilla","year":"2017","unstructured":"Rohilla A, Khare G, Tyagi AK (2017) Virtual screening, pharmacophore development and structure based similarity search to identify inhibitors against IdeR, a transcription factor of Mycobacterium tuberculosis. Sci Rep 7:1\u201314. https:\/\/doi.org\/10.1038\/s41598-017-04748-9","journal-title":"Sci Rep"},{"key":"6611_CR117","doi-asserted-by":"publisher","unstructured":"Salimizand H, Jamehdar SA, Nik LB, Sadeghian H (2017) Design of peptides interfering with iron-dependent regulator (IdeR) and evaluation of Mycobacterium tuberculosis growth inhibition. Iran J Basic Med Sci 20:722\u2013728. https:\/\/doi.org\/10.22038\/ijbms.2017.8859","DOI":"10.22038\/ijbms.2017.8859"},{"key":"6611_CR118","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1006\/jmbi.1998.2339","volume":"285","author":"E Pohl","year":"1999","unstructured":"Pohl E, Holmes RK, Hol WGJ (1999) Crystal structure of the iron-dependent regulator (IdeR) from Mycobacterium tuberculosis shows both metal binding sites fully occupied. J Mol Biol 285:1145\u20131156. https:\/\/doi.org\/10.1006\/jmbi.1998.2339","journal-title":"J Mol Biol"},{"key":"6611_CR119","doi-asserted-by":"publisher","first-page":"5988","DOI":"10.1128\/IAI.73.9.5988-5994.2005","volume":"73","author":"YC Manabe","year":"2005","unstructured":"Manabe YC, Hatem CL, Kesavan AK et al (2005) Both Corynebacterium diphtheriae DtxR(E175K) and Mycobacterium tuberculosis IdeR(D177K) are dominant positive repressors of IdeR-regulated genes in M. tuberculosis. Infect Immun 73:5988\u20135994. https:\/\/doi.org\/10.1128\/IAI.73.9.5988-5994.2005","journal-title":"Infect Immun"},{"key":"6611_CR120","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1093\/bioinformatics\/bti375","volume":"21","author":"P Prakash","year":"2005","unstructured":"Prakash P, Yellaboina S, Ranjan A, Hasnain SE (2005) Computational prediction and experimental verification of novel IdeR binding sites in the upstream sequences of Mycobacterium tuberculosis open reading frames. Bioinformatics 21:2161\u20132166. https:\/\/doi.org\/10.1093\/bioinformatics\/bti375","journal-title":"Bioinformatics"},{"key":"6611_CR121","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3109\/1040841X.2011.606425","volume":"37","author":"KF Siddiqui","year":"2011","unstructured":"Siddiqui KF, Amir M, Agrewala JN (2011) Understanding the biology of 16 kDa antigen of Mycobacterium tuberculosis: scope in diagnosis, vaccine design and therapy. Crit Rev Microbiol 37:349\u2013357. https:\/\/doi.org\/10.3109\/1040841X.2011.606425","journal-title":"Crit Rev Microbiol"},{"key":"6611_CR122","doi-asserted-by":"publisher","unstructured":"Krishnan G, Roy U (2018) Prediction of recombinant Mycobacterium tuberculosis \u03b1-crystallin oligomer chaperone activity using polynomial graphs [version 1; peer review: 1 approved]. F1000Research 7:1\u201312. https:\/\/doi.org\/10.12688\/F1000RESEARCH.16328.1","DOI":"10.12688\/F1000RESEARCH.16328.1"},{"key":"6611_CR123","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1159\/000492887","volume":"49","author":"B Jee","year":"2018","unstructured":"Jee B, Singh Y, Yadav R, Lang F (2018) Small heat shock protein 16.3 of Mycobacterium tuberculosis: after two decades of functional characterization. Cell Physiol Biochem 49:368\u2013380. https:\/\/doi.org\/10.1159\/000492887","journal-title":"Cell Physiol Biochem"},{"key":"6611_CR124","doi-asserted-by":"publisher","first-page":"7534","DOI":"10.1073\/pnas.121172498","volume":"98","author":"DR Sherman","year":"2001","unstructured":"Sherman DR, Voskuil M, Schnappinger D et al (2001) Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding \u03b1-crystallin. Proc Natl Acad Sci U S A 98:7534\u20137539. https:\/\/doi.org\/10.1073\/pnas.121172498","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6611_CR125","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1128\/JB.00443-20","volume":"202","author":"H He","year":"2020","unstructured":"He H, Hovey R, Kane J et al (2020) MprAB is a stress-responsive two-component system that directly regulates expression of sigma factors SigB and SigE in Mycobacterium tuberculosis. J Bacteriol 202:2134\u20132143. https:\/\/doi.org\/10.1128\/JB.00443-20","journal-title":"J Bacteriol"},{"key":"6611_CR126","doi-asserted-by":"publisher","first-page":"6213","DOI":"10.1128\/JB.00492-07","volume":"189","author":"X Pang","year":"2007","unstructured":"Pang X, Howard ST (2007) Regulation of the \u03b1-crystallin gene acr2 by the MprAB two-component system of Mycobacterium tuberculosis. J Bacteriol 189:6213\u20136221. https:\/\/doi.org\/10.1128\/JB.00492-07","journal-title":"J Bacteriol"},{"key":"6611_CR127","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1128\/IAI.01443-07","volume":"76","author":"HM Vasudeva-Rao","year":"2008","unstructured":"Vasudeva-Rao HM, McDonough KA (2008) Expression of the Mycobacterium tuberculosis acr-coregulated genes from the DevR (DosR) regulon is controlled by multiple levels of regulation. Infect Immun 76:2478\u20132489. https:\/\/doi.org\/10.1128\/IAI.01443-07","journal-title":"Infect Immun"},{"key":"6611_CR128","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1128\/IAI.00974-07","volume":"76","author":"P Font\u00e1n","year":"2008","unstructured":"Font\u00e1n P, Aris V, Ghanny S et al (2008) Global transcriptional profile of Mycobacterium tuberculosis during THP-1 human macrophage infection. Infect Immun 76:717\u2013725. https:\/\/doi.org\/10.1128\/IAI.00974-07","journal-title":"Infect Immun"},{"key":"6611_CR129","doi-asserted-by":"publisher","first-page":"5777","DOI":"10.1128\/IAI.69.9.5777-5785.2001","volume":"69","author":"Florczyk","year":"2001","unstructured":"Florczyk et al (2001) Identification and characterization of mycobacterial proteins differentially expressed understanding and shaking culture conditions, including Rv2623 from a novel class of putative ATP-binding proteins. Infect Immun 69:5777\u20135785. https:\/\/doi.org\/10.1128\/IAI.69.9.5777-5785.2001","journal-title":"Infect Immun"},{"key":"6611_CR130","doi-asserted-by":"publisher","first-page":"9578","DOI":"10.1073\/pnas.95.16.9578","volume":"95","author":"Y Yuan","year":"1998","unstructured":"Yuan Y, Crane DD, Simpson RM et al (1998) The 16-kDa \u03b1-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages. Proc Natl Acad Sci USA 95:9578\u20139583. https:\/\/doi.org\/10.1073\/pnas.95.16.9578","journal-title":"Proc Natl Acad Sci USA"},{"key":"6611_CR131","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2174\/156652407780598548","volume":"7","author":"S Waddell","year":"2007","unstructured":"Waddell S, Butcher P (2007) Microarray analysis of whole genome expression of intracellular Mycobacterium tuberculosis. Curr Mol Med 7:287\u2013296. https:\/\/doi.org\/10.2174\/156652407780598548","journal-title":"Curr Mol Med"},{"key":"6611_CR132","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1155\/2019\/2532045","volume":"2019","author":"G Krishnan","year":"2019","unstructured":"Krishnan G, Roy U (2019) A new functional model for prediction of chaperone activity of the recombinant M. tb Acr ( -Crystallin) using insulin as substrate. Can J Infect Dis Med Microbiol 2019:8\u201310. https:\/\/doi.org\/10.1155\/2019\/2532045","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"6611_CR133","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.bmcl.2016.11.084","volume":"27","author":"S Chetty","year":"2017","unstructured":"Chetty S, Ramesh M, Singh-Pillay A, Soliman MES (2017) Recent advancements in the development of anti-tuberculosis drugs. Bioorganic Med Chem Lett 27:370\u2013386. https:\/\/doi.org\/10.1016\/j.bmcl.2016.11.084","journal-title":"Bioorganic Med Chem Lett"},{"key":"6611_CR134","doi-asserted-by":"publisher","first-page":"21714","DOI":"10.1074\/jbc.M113.453076","volume":"288","author":"CP Owens","year":"2013","unstructured":"Owens CP, Chim N, Graves AB et al (2013) The Mycobacterium tuberculosis secreted protein Rv0203 transfers heme to membrane proteins MmpL3 and MmpL11. J Biol Chem 288:21714\u201321728. https:\/\/doi.org\/10.1074\/jbc.M113.453076","journal-title":"J Biol Chem"},{"key":"6611_CR135","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1128\/AAC.05708-11","volume":"56","author":"K Tahlan","year":"2012","unstructured":"Tahlan K, Wilson R, Kastrinsky DB et al (2012) SQ109 targets MmpL3, a membrane transporter of trehalose monomycolate involved in mycolic acid donation to the cell wall core of Mycobacterium tuberculosis. Antimicrob Agents Chemother 56:1797\u20131809. https:\/\/doi.org\/10.1128\/AAC.05708-11","journal-title":"Antimicrob Agents Chemother"},{"key":"6611_CR136","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1099\/mic.0.2008\/017434-0","volume":"154","author":"V Bhowruth","year":"2008","unstructured":"Bhowruth V, Brown AK, Besra GS (2008) Synthesis and biological evaluation of NAS-21 and NAS-91 analogues as potential inhibitors of the mycobacterial FAS-II dehydratase enzyme Rv0636. Microbiology 154:1866\u20131875. https:\/\/doi.org\/10.1099\/mic.0.2008\/017434-0","journal-title":"Microbiology"},{"key":"6611_CR137","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1021\/acs.chemrev.7b00602","volume":"118","author":"T Yuan","year":"2018","unstructured":"Yuan T, Sampson NS (2018) Hit generation in TB drug discovery: from genome to granuloma. Chem Rev 118:1887\u20131916. https:\/\/doi.org\/10.1021\/acs.chemrev.7b00602","journal-title":"Chem Rev"},{"key":"6611_CR138","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1039\/c3md00016h","volume":"4","author":"GAI Moustafa","year":"2013","unstructured":"Moustafa GAI, Nojima S, Yamano Y et al (2013) Potent growth inhibitory activity of (\u00b1)-platencin towards multi-drug-resistant and extensively drug-resistant Mycobacterium tuberculosis. Medchemcomm 4:720\u2013723. https:\/\/doi.org\/10.1039\/c3md00016h","journal-title":"Medchemcomm"},{"key":"6611_CR139","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1128\/AAC.47.9.2903-2913.2003","volume":"47","author":"JC Betts","year":"2003","unstructured":"Betts JC, McLaren A, Lennon MG et al (2003) Signature gene expression profiles discriminate between isoniazid-, thiolactomycin-, and triclosan-treated Mycobacterium tuberculosis. Antimicrob Agents Chemother 47:2903\u20132913. https:\/\/doi.org\/10.1128\/AAC.47.9.2903-2913.2003","journal-title":"Antimicrob Agents Chemother"},{"key":"6611_CR140","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.bbrc.2017.08.119","volume":"498","author":"LA Defelipe","year":"2018","unstructured":"Defelipe LA, Osman F, Marti MA, Turjanski AG (2018) Structural and mechanistic comparison of the cyclopropane mycolic acid synthases (CMAS) protein family of Mycobacterium tuberculosis. Biochem Biophys Res Commun 498:288\u2013295. https:\/\/doi.org\/10.1016\/j.bbrc.2017.08.119","journal-title":"Biochem Biophys Res Commun"},{"key":"6611_CR141","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100829","author":"FC Chen","year":"2014","unstructured":"Chen FC, Liao YC, Huang JM et al (2014) Pros and cons of the tuberculosis drugome approach\u2014an empirical analysis. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0100829","journal-title":"PLoS ONE"},{"key":"6611_CR142","doi-asserted-by":"publisher","first-page":"12989","DOI":"10.1073\/pnas.2134250100","volume":"100","author":"CM Sassetti","year":"2003","unstructured":"Sassetti CM, Rubin EJ (2003) Genetic requirements for mycobacterial survival during infection. Proc Natl Acad Sci USA 100:12989\u201312994. https:\/\/doi.org\/10.1073\/pnas.2134250100","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06611-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-021-06611-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06611-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T07:27:18Z","timestamp":1629358038000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-021-06611-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":142,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["6611"],"URL":"https:\/\/doi.org\/10.1007\/s11033-021-06611-7","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"11 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study did not require ethical approval.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors have seen the manuscript and approved its submission.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}